ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 198 filers reported holding ACORDA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $75,000 | -54.0% | 80,010 | +0.1% | 0.00% | – |
| Q4 2019 | $163,000 | -29.4% | 79,910 | -0.5% | 0.00% | – |
| Q3 2019 | $231,000 | -71.7% | 80,330 | -24.5% | 0.00% | -100.0% |
| Q2 2019 | $816,000 | -14.4% | 106,330 | +48.2% | 0.00% | 0.0% |
| Q1 2019 | $953,000 | -14.8% | 71,730 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,118,000 | -25.9% | 71,730 | -6.6% | 0.00% | 0.0% |
| Q3 2018 | $1,509,000 | -31.5% | 76,800 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $2,204,000 | +50.4% | 76,800 | +24.0% | 0.00% | +100.0% |
| Q1 2018 | $1,465,000 | -32.3% | 61,930 | -38.6% | 0.00% | -50.0% |
| Q4 2017 | $2,163,000 | +27.7% | 100,860 | +40.8% | 0.00% | +100.0% |
| Q3 2017 | $1,694,000 | +20.1% | 71,630 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,411,000 | -57.0% | 71,630 | -54.2% | 0.00% | -66.7% |
| Q1 2017 | $3,282,000 | +192.3% | 156,290 | +161.7% | 0.00% | +200.0% |
| Q4 2016 | $1,123,000 | -14.4% | 59,730 | -4.9% | 0.00% | 0.0% |
| Q3 2016 | $1,312,000 | -56.8% | 62,830 | -47.2% | 0.00% | -66.7% |
| Q2 2016 | $3,034,000 | +52.5% | 118,944 | +58.1% | 0.00% | +50.0% |
| Q1 2016 | $1,989,000 | -37.1% | 75,214 | +1.8% | 0.00% | -33.3% |
| Q4 2015 | $3,162,000 | +56.5% | 73,914 | -3.0% | 0.00% | +50.0% |
| Q3 2015 | $2,021,000 | -20.5% | 76,230 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $2,543,000 | +0.1% | 76,310 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,540,000 | -18.6% | 76,310 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $3,119,000 | +20.7% | 76,310 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $2,585,000 | -8.3% | 76,310 | -8.7% | 0.00% | 0.0% |
| Q2 2014 | $2,818,000 | -11.1% | 83,610 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $3,170,000 | +19.4% | 83,610 | -8.1% | 0.00% | +50.0% |
| Q4 2013 | $2,656,000 | -14.8% | 90,972 | +0.0% | 0.00% | -33.3% |
| Q3 2013 | $3,117,000 | +3.9% | 90,931 | -0.0% | 0.00% | 0.0% |
| Q2 2013 | $3,000,000 | – | 90,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |